Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Saturday, December 12, 2015 4:28:35 PM
bullish 57.53
moving average breakout
gap up
moving average support
island reversal
http://www.glpg.com/
## source: finance.yahoo.com
Tue, 08 Dec 2015 16:32:47 GMT ~ Here's Why Galapagos NV's Shares Are Soaring Today
read full: http://www.fool.com/investing/general/2015/12/08/heres-why-galapagos-nvs-shares-are-soaring-today.aspx?source=eogyholnk0000001&utm_source=yahoo&utm_medium=feed&utm_campaign=article
*********************************************************
Mon, 07 Dec 2015 22:44:17 GMT ~ Filgotinib meets primary endpoint in phase 2 study in patients with moderate to severe Crohn's disease
[at noodls] - Press release Regulated information 7 December 2015, 22.30 CET First JAK-inhibitor to show efficacy in Crohn's disease 48% clinical remission rate, statistically significant versus placebo after 10 weeks ...
read full: http://www.noodls.com/view/7144141FFFE7E3FD1C28343ED3DC414393F264CA
*********************************************************
Thu, 03 Dec 2015 16:23:52 GMT ~ Galapagos NV Earnings Q3, 2015
read full: http://www.capitalcube.com/blog/index.php/galapagos-nv-earnings-q3-2015/
*********************************************************
Fri, 27 Nov 2015 12:36:45 GMT ~ Is Argo Group International Holdings, Ltd. (AGII) A Good Stock To Buy?
read full: http://www.insidermonkey.com/blog/is-argo-group-international-holdings-ltd-agii-a-good-stock-to-buy-391053/
*********************************************************
Mon, 23 Nov 2015 16:08:07 GMT ~ Hedge Funds Like What They See From Cyberonics, Inc. (CYBX)
read full: http://www.insidermonkey.com/blog/hedge-funds-like-what-they-see-from-cyberonics-inc-cybx-386892/
*********************************************************
$GLPG charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$GLPG company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/GLPG/company-info
Ticker: $GLPG
OTC Market Place: Not Available
CIK code: 0001421876
Company name: Galapagos N.V.
Company website: http://www.glpg.com
Incorporated In: Belgium
Business Description: Galapagos is a midsized biotechnology company, with therapeutic programs based on proprietary disease modifying drug targets, and a focus on inflammation, orphan disease, and anti-infectives. Galapagos' approach is to develop drugs that stop or reverse a disease state using novel targets that are identified through a patent protected target discovery platform. Galapagos also provides access to its target and drug discovery platform through its services division, BioFocus and Argenta, which offers a full suite of target-to-drug discovery products and services to pharmaceutical and biotech companies.Less >>
$GLPG share structure
## source: otcmarkets.com
Market Value: $1,540,121,075 a/o Dec 11, 2015
Shares Outstanding: 26,770,747 a/o Dec 31, 2012
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$GLPG extra dd links
Company name: Galapagos N.V.
Company website: http://www.glpg.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=GLPG+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=GLPG+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=GLPG+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/GLPG/news - http://finance.yahoo.com/q/h?s=GLPG+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/GLPG/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/GLPG/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=GLPG+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/GLPG
DTCC (dtcc.com): http://search2.dtcc.com/?q=Galapagos+N.V.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Galapagos+N.V.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Galapagos+N.V.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.glpg.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.glpg.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.glpg.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/GLPG
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001421876&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/GLPG/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/GLPG/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=GLPG&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=GLPG
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/GLPG/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=GLPG+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=GLPG+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=GLPG
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=GLPG
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=GLPG+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/GLPG/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=GLPG+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/GLPG.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=GLPG
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/GLPG/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/GLPG/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/GLPG
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/GLPG
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/GLPG:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=GLPG
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=GLPG
$GLPG DD Notes ~ http://www.ddnotesmaker.com/GLPG
Recent GLPG News
- Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 • GlobeNewswire Inc. • 04/04/2024 08:01:00 PM
- Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings • GlobeNewswire Inc. • 03/28/2024 08:01:00 PM
- Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board • GlobeNewswire Inc. • 03/26/2024 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2024 11:41:59 AM
- Galapagos announces full year 2023 results and outlook for 2024 • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/16/2024 11:00:09 AM
- Galapagos presents at EBMT-EHA annual meeting 2024 • GlobeNewswire Inc. • 02/15/2024 09:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 10:41:32 PM
- Galapagos completes transaction to transfer Jyseleca® business to Alfasigma • GlobeNewswire Inc. • 01/31/2024 09:01:00 PM
- Galapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer Drug • Dow Jones News • 01/04/2024 09:44:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/04/2024 09:07:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/04/2024 09:05:08 PM
- Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S. • GlobeNewswire Inc. • 01/04/2024 09:01:00 PM
- BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets • PR Newswire (US) • 01/03/2024 09:01:00 PM
- Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology • GlobeNewswire Inc. • 01/03/2024 09:01:00 PM
- Galapagos signs agreement to transfer Jyseleca® business to Alfasigma • GlobeNewswire Inc. • 01/02/2024 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/21/2023 09:03:59 PM
- Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301 • GlobeNewswire Inc. • 12/19/2023 09:01:00 PM
- Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101 • GlobeNewswire Inc. • 12/09/2023 05:00:00 PM
- Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023 • GlobeNewswire Inc. • 12/07/2023 09:01:00 PM
- Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care • PR Newswire (US) • 11/06/2023 12:45:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/03/2023 12:26:11 PM
- Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023 • GlobeNewswire Inc. • 11/02/2023 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/02/2023 11:15:54 AM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM